samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Top ten tasks to prepare for the UK Conformity Assessment

Maetrics




November 2020 – As the medical device industry gears up to implement a new set of requirements following Brexit, Maetrics has released a concise guide summarizing the known requirements so far and priority areas where manufacturers can give their immediate attention.

As manufacturers work hard towards compliance with the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), it is important not to overlook another pending challenge: businesses with products on the UK market will need to comply with the requirements of the UK’s new regulatory regime. The delay of the EU MDR date of implementation to May 2021 means that manufacturers have time to start planning. Moreover, EU MDR and IVDR compliance activities are likely to place them in good stead for the emerging post-Brexit system.

One of the first action points for affected organizations will be to monitor developments and assess the level of overlap between the EU and UK regulatory regimes to prevent unnecessary duplication of efforts. As more information becomes available, Maetrics’ new guide provides a list of ten actions that manufacturers can build into their regulatory planning, and clearly breaks down what we already know about the UK Conformity Assessment certification (UKCA mark).

Steve Cottrell, President at Maetrics, comments: “Our industry is facing a number of ongoing regulatory pressures, and this makes strategic planning more critical than ever. Maetrics’ aim with this mini-guide is to provide an easily absorbed overview that will help with preparations for the UK’s upcoming certification. Businesses should immediately begin to identify where more information is still needed, as well as potential areas of complexity. These information gaps can then be filled in and addressed efficiently as and when there are new developments.”

The guide is available to download here: https://bit.ly/3m0fEKx

phone 1-877-623-8742
email information@maetrics.com
web www.maetrics.com
email 9000 Keystone Crossing Suite 230, Indianapolis, IN 46240
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Calyx Supports Breakthrough Therapy Approvals for Oncology Treatments

Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that its Medical Imaging and other eClinical solutions supported half of the oncology treatments approved by the FDA as Breakthrough Therapies in the past two years.
More info >>


White Papers

galenIQ - The smart excipient

BENEO GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement